Edwards Lifesciences Earnings & Forecasts

Edwards Lifesciences (EW) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

四半期利益の驚きの金額

会計四半期	報告日	実質EPS	推定EPS	驚き％
Q2	Jul 23, 2026	$0.78	$0.74	5.41 %
Q1	Apr 23, 2026	$0.78	$0.73	6.85 %
Q4	Feb 10, 2026	$0.58	$0.62	-6.45 %
Q3	Oct 30, 2025	$0.67	$0.59	13.6 %

Quarterly Revenue (Billions)

四半期売上高の驚きの金額

会計四半期	報告日	実際の収益	推定収益	驚き％
Q2	Jul 23, 2026	$1.74B	$1.70B	2.42 %
Q1	Apr 23, 2026	$1.65B	$1.59B	3.41 %
Q4	Feb 10, 2026	$1.57B	$1.54B	1.81 %
Q3	Oct 30, 2025	$1.55B	$1.50B	3.66 %

Edwards Lifesciences Guidance

Edwards Lifesciences (EW) は、7 23, 2026 年に Q3 2026 のガイダンスを最後に発表しました。同社は 1 株当たり利益を $0.71 - $0.77 の範囲と予想し、コンセンサス EPS 予想は $0.74 でした。Edwards Lifesciences も、この期間の売上高を $1.63B - $1.71B の範囲と予想しました。

以前のガイダンスと比較して、Edwards Lifesciencesは売上高予測を以前の範囲である引き下げから$6.6B - $6.9Bに引き上げました。

Edwards Lifesciencesは、40から10 27, 2022の間に7 23, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 6 times and lowered it 17 times, providing investors with insight into management's evolving expectations.

Recent Earnings Results

Metric	Q2 '26	Q1 '26	Q4 '25	Q3 '25
Earnings Per Share (Non-GAAP)
Estimate	$0.74	$0.73	$0.62	$0.59
Actual	$0.78	$0.78	$0.58	$0.67
Surprise	+5.41%	+6.85%	-6.45%	+13.6%
Revenue
Estimate	$1.70B	$1.59B	$1.54B	$1.50B
Actual	$1.74B	$1.65B	$1.57B	$1.55B
Surprise	+2.42%	+3.41%	+1.81%	+3.66%

Analyst Estimates — Forward PeriodsSource: Wall Street consensus

Metric	Q3 '26E	Q4 '26E	Q1 '27E	Q2 '27E
Earnings Per Share (Non-GAAP)
Consensus	$0.74	$0.71	$0.84	$0.86
Revenue
Consensus	$1.68B	$1.70B	—	—

More with Benzinga EdgeGet Access

Earnings & Guidance News

Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says

Edwards Lifesciences tops Q2 Wall Street estimates with $1.74B in revenue. EW stock jumps as analysts see continued upside ahead.

Vandana Singh

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Lifesciences, SAP in Focus (UPDATED)

U.S. stock futures were higher on Friday, as the Dow Jones, S&P 500 and Nasdaq 100 indices rose, following Thursday's lower close.

Rishabh Mishra

American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday

US stock futures mixed, focus on companies like American Express, Deckers, Verizon, Edwards Lifesciences, and HCA Healthcare for today's trading.

Avi Kapoor

PRO
Edwards Lifesciences Sees Q3 Adj EPS $0.71-$0.77 vs $0.74 Est; Sees Sales $1.630B-$1.710B vs $1.689B Est

Edwards Lifesciences (NYSE:EW) is looking for Q3 Adj EPS of $0.71-$0.77 vs $0.74 analyst estimate. sees sales of $1.630 billion-$1.710 billion vs $1.689 billion analyst estimate.

Benzinga Newsdesk

PRO
Edwards Lifesciences Affirms FY2026 Adj EPS Guidance of $2.95-$3.05 vs $3.01 Est; Raises FY2026 Sales Guidance from $6.500B-$6.900B to $6.600B-$6.900B vs $6.745B Est

Edwards Lifesciences (NYSE:EW) affirms FY2026 Adj EPS guidance from $2.95-$3.05 to $2.95-$3.05 vs $3.01 analyst estimate. Raises FY2026 sales outlook from $6.500 billion-$6.900 billion to $6.600 billion-$6.900 billion

Benzinga Newsdesk

PRO
Edwards Lifesciences Q2 Adj. EPS $0.78 Beats $0.74 Estimate, Sales $1.741B Beat $1.700B Estimate

Edwards Lifesciences (NYSE:EW) reported quarterly earnings of $0.78 per share which beat the analyst consensus estimate of $0.74 by 5.41 percent. This is a 16.42 percent increase over earnings of $0.67 per share from

Benzinga Newsdesk

Edwards Lifesciences Corp